Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-07-17

Clinical Trial Update: Clinical Study on the Safety and Preliminary Efficacy of hUC-MSCs Intravenous Infusion Therapy for ARDS [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on a Phase 1/2 study evaluating the safety and preliminary efficacy of intravenous hUC-MSCs for acute respiratory distress syndrome; recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • hUC-MSCs Intravenous Infusion Therapy (human umbilical cord-derived mesenchymal stem cells)

Snippet

Sponsor: Southeast University, China | Conditions: Acute Respiratory Distress Syndrome | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING